Velan Capital Investment Management LP Edesa Biotech, Inc. Transaction History

Velan Capital Investment Management LP

  • $41.8 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.91 - $2.63 $357,381 - $1.03 Million
392,727 Added 44.18%
1,281,615 $1.17 Million
Q4 2022

Feb 13, 2023
BUY
$0.8 - $8.05 $711,110 - $7.16 Million
888,888 New
888,888 $1.92 Million

About Edesa Biotech, Inc.

EDSA Quotes by TradingView
  • Ticker EDSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,462,300
  • Market Cap $38.2M
  • Description
  • Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...
More about EDSA
Track This Portfolio

Track Velan Capital Investment Management LP Portfolio

Follow Velan Capital Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Velan Capital Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Velan Capital Investment Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email